Stanley Glassman has been appointed chief business development officer of Adaptis (Seattle), which provides business process outsourcing services to the healthcare industry, Glassman served most recently as the division president and corporate senior vice president of St. Vincent Catholic Medical Centers of New York.

William Caldwell IV has been appointed CEO and Dr. Michael West as chairman, president and chief scientific officer of Advanced Cell Technology (Worcester, Massachusetts). The appointments were concurrent with the initial closing of the company's Series A financing on Dec. 31. Caldwell brings more than 30 years of management expertise to Advanced Cell Technology, and has worked with emerging technology companies, public companies and corporate restructurings. West has served as chairman and CEO of the company since 1999. Advanced Cell Technology is focused on discovering and commercializing advances in stem cell technology for application in regenerative medicine.

William Sullivan has been elected president and CEO of Agilent Technologies (Palo Alto, California), effective March 1. Sullivan, currently executive vice president and chief operating officer, succeeds Edward Barnholt, who has announced his retirement as chairman, president and CEO of the company he helped launch following its spin-off from Hewlett-Packard in 1999. Barnholt had previously been an executive vice president of HP and general manager of its measurement organization that incorporated all of Agilent's business groups. James Cullen, who has served on Agilent's board of directors since 2000, will assume the position of non-executive chairman upon Barnholt's retirement. Sullivan will join the board at that time, and Barnholt will stay on as chairman emeritus to ensure a smooth transition. Agilent is a global technology leader in communications, electronics, life sciences and chemical analysis.

Peter Wulff has been named CFO of Artes Medical (San Diego), a privately held specialty pharmaceutical and medical device company. Prior to joining Artes Medical, Wulff served as CFO at several public and privately held healthcare companies, most recently at CryoCor. Artes Medical helps physicians in the facial aesthetics market improve patient outcomes through Aesthetic Tissue Engineering, including its lead product, ArteFill.

• Biolase Technology (San Clemente, California), a medical technology company that manufactures lasers and related products focused on improving dental procedures, reported several executive appointments. James Haefner has been named executive vice president of sales, Keith Bateman executive vice president of marketing and Douglas Downing vice president of operations. Additionally, Jeffrey Jones, chief technology officer and vice chairman of the board of directors, will be responsible for all research and development activities and product development initiatives, and John Hohener, CFO, will be responsible for all infrastructure functions, including finance, accounting, customer service, human resources, IT and legal affairs. Prior to joining Biolase, Haefner held numerous management positions at Coherent and Lumenis. Bateman joined the company in 1999. Downing joined Biolase in May 2004 and has been serving as director of global operations.

Dr. Paula Mendenhall has joined Durect (Cupertino, California), an emerging drug delivery company, as senior vice president of operations. She has more than 30 years of pharmaceutical experience covering areas such as research, manufacturing and pharmaceutical operations. Most recently, Mendenhall has been a consultant for various companies for in-house and outsourcing of pharmaceutical manufacturing. Durect is focused on the development of pharmaceutical systems based on its drug delivery platform technologies.

Alan Beauchamp has joined Dynacq Healthcare (Houston) as chief operating officer. Beauchamp previously was CEO of Doctors Hospital Parkway and Doctors Hospital Tidwell. Dynacq is a holding company, with its subsidiaries providing surgical healthcare services and related ancillary services through hospital facilities and outpatient surgical centers.

James Torina, a founder and CEO of Integrated Healthcare Systems (IHS; Kent, Washington), has assumed the additional duties of president of the provider of automated equipment and software to pharmacies that package, barcode, store and track drug inventories.

Michael Mainelli has been named president of the Invivo subsidiary of Intermagnetics General (Latham, New York), with overall responsibility for Intermagnetics' medical device businesses. Before joining Intermagnetics, Mainelli was president of Stryker Spine and prior to that was president of Stryker Japan. Before joining Stryker, Mainelli spent more than 12 years with General Electric, primarily within GE Medical Systems. Thomas O'Brien, who has served as Invivo's interim president for the past year, will now focus on his primary responsibilities as executive vice president of corporate development. Intermagnetics' Medical Devices business segment consists of Invivo Diagnostic Imaging division, with facilities in Gainesville, Florida, and Pewaukee, Wisconsin, and Invivo Patient Care division in Orlando, Florida, and Valencia, California. The businesses employ more than 600.

Scott Long has joined Sanarus Medical (Pleasanton, California) as vice president of sales, joining the company from SenoRx. He has more than 22 years of medical device industry sales and sale management experience. Sanarus is an early commercialization stage company focused on minimally invasive diagnostic and treatment devices for breast disease, including the Cassi Biopsy Device.

No Comments